scholarly journals Fetal valproate syndrome

2020 ◽  
Author(s):  

2008 ◽  
Vol 36 (4) ◽  
pp. 361-369 ◽  
Author(s):  
Arnold L. Christianson ◽  
Nicole Chester ◽  
Jennifer G. R. Kromberg


2018 ◽  
Vol 80 ◽  
pp. 26
Author(s):  
Francesca Di Renzo ◽  
Renato Bacchetta ◽  
Maria Battistoni ◽  
Elena Menegola


1987 ◽  
Vol 111 (2) ◽  
pp. 308-309 ◽  
Author(s):  
Guy Massa ◽  
Dominique Lecoutere ◽  
Paul Casaer


2018 ◽  
Vol 1 (1) ◽  

Background: Fetal Valproate Syndrome (FVS) results from prenatal exposure to valproic acid (VPA). Case characteristics: A four year old female child presented with facial dysmorphism and features of autism spectrum disorder (ASD). She had in-utero exposure to valproic acid (VPA). Message: VPA to be avoided in pregnancy and in Dysmorphism or ASD children maternal anti- convulsant drug history must be taken.



2013 ◽  
Vol 9 (4) ◽  
pp. 165-166
Author(s):  
Charles Smith


1995 ◽  
Vol 32 (9) ◽  
pp. 724-727 ◽  
Author(s):  
J Clayton-Smith ◽  
D Donnai


2006 ◽  
Vol 7 (3) ◽  
pp. 123-130 ◽  
Author(s):  
Usha Kini


2003 ◽  
Vol 70 (8) ◽  
pp. 681-682 ◽  
Author(s):  
P. Anoop ◽  
C. K. Sasidharan


2014 ◽  
Vol 20 (2) ◽  
pp. 187 ◽  
Author(s):  
ParmarthG Chandane ◽  
Ira Shah


2017 ◽  
Vol 163 (5) ◽  
pp. 605-607
Author(s):  
E. A. Ivanova ◽  
I. G. Kapitsa ◽  
N. N. Zolotov ◽  
V. F. Pozdnev ◽  
T. A. Voronina


Sign in / Sign up

Export Citation Format

Share Document